Diabetes Kongress 2019
zur Liste
Dr. Stefan Kaspers
Boehringer Ingelheim International GmbH Germany
  • Vortrag Empagliflozin reduces mortality and hospitalisation for heart failure in patients with or without a history of myocardial infarction or stroke at baseline Speaker
    Datum: 31.05.2019 , Zeit: 11:25 | Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe
    Details